FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115086893> ?p ?o ?g. }

• W2115086893 endingPage "2105" @default.
• W2115086893 startingPage "2099" @default.
• W2115086893 abstract "In this study, we developed a nanoparticulate nystatin formulation and performed a comparative evaluation against a commercial nystatin preparation of its in vitro and in vivo antifungal activities. A nystatin nanosuspension was prepared from a commercially available suspension by wet-media milling. The nanosuspension was characterized for particle size by laser diffraction and assayed for content by HPLC. Its in vitro activity was evaluated against Candida albicans strains SC5314 and LAM-1 (12.5–5000 μg/mL) using an agar plate assay and its in vivo efficacy was evaluated using a murine model of oral candidiasis. Briefly, DBA/2 mice were immunosuppressed with cortisone acetate, orally infected with C. albicans strain LAM-1, and treated for 14 days with conventional nystatin suspension, nystatin nanosuspension or saline control. Efficacy endpoints were oral fungal burden, mouse survival and organ histopathology. A single-dose pharmacokinetic study was also performed. The median particle size of the nystatin suspension was reduced from 6577 to 137 nm. The HPLC assay demonstrated a nystatin content of 98.7% ± 0.8% of the label claim. In vitro activity was superior to that of the conventional nystatin suspension at 100–5000 μg/mL concentrations. Beginning on day 3 of treatment, lower oral burdens of C. albicans were found in the nanosuspension group compared with the suspension and control groups. Mouse survival was also superior in the nanosuspension group. No systemic absorption was observed. Taken together, these data reveal that nanonization of nystatin provides a novel approach to enhancing its efficacy in the treatment of oral candidiasis." @default.
• W2115086893 created "2016-06-24" @default.
• W2115086893 creator A5060855573 @default.
• W2115086893 creator A5066649593 @default.
• W2115086893 creator A5083326667 @default.
• W2115086893 creator A5086985620 @default.
• W2115086893 creator A5087834899 @default.
• W2115086893 creator A5089122298 @default.
• W2115086893 date "2013-04-25" @default.
• W2115086893 modified "2023-10-11" @default.
• W2115086893 title "Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans" @default.
• W2115086893 cites W1513092465 @default.
• W2115086893 cites W1540650391 @default.
• W2115086893 cites W1967254719 @default.
• W2115086893 cites W1968898131 @default.
• W2115086893 cites W1978958698 @default.
• W2115086893 cites W2000364560 @default.
• W2115086893 cites W2001577018 @default.
• W2115086893 cites W2013859315 @default.
• W2115086893 cites W2014083454 @default.
• W2115086893 cites W2021381458 @default.
• W2115086893 cites W2027420234 @default.
• W2115086893 cites W2029619837 @default.
• W2115086893 cites W2043751393 @default.
• W2115086893 cites W2049505636 @default.
• W2115086893 cites W2051236556 @default.
• W2115086893 cites W2054896665 @default.
• W2115086893 cites W2057657739 @default.
• W2115086893 cites W2058261141 @default.
• W2115086893 cites W2060721894 @default.
• W2115086893 cites W2068402403 @default.
• W2115086893 cites W2069060403 @default.
• W2115086893 cites W2091814579 @default.
• W2115086893 cites W2124339021 @default.
• W2115086893 cites W2128546265 @default.
• W2115086893 cites W2132081026 @default.
• W2115086893 cites W2132882111 @default.
• W2115086893 cites W2134900294 @default.
• W2115086893 cites W2137631594 @default.
• W2115086893 cites W2148260760 @default.
• W2115086893 cites W2150428940 @default.
• W2115086893 cites W2162751259 @default.
• W2115086893 cites W2164812014 @default.
• W2115086893 cites W2166412516 @default.
• W2115086893 cites W2170908195 @default.
• W2115086893 cites W30241777 @default.
• W2115086893 cites W4210968368 @default.
• W2115086893 cites W4242190998 @default.
• W2115086893 cites W47211728 @default.
• W2115086893 doi "https://doi.org/10.1093/jac/dkt137" @default.
• W2115086893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23620465" @default.
• W2115086893 hasPublicationYear "2013" @default.
• W2115086893 type Work @default.
• W2115086893 sameAs 2115086893 @default.
• W2115086893 citedByCount "29" @default.
• W2115086893 countsByYear W21150868932014 @default.
• W2115086893 countsByYear W21150868932015 @default.
• W2115086893 countsByYear W21150868932016 @default.
• W2115086893 countsByYear W21150868932017 @default.
• W2115086893 countsByYear W21150868932018 @default.
• W2115086893 countsByYear W21150868932019 @default.
• W2115086893 countsByYear W21150868932022 @default.
• W2115086893 countsByYear W21150868932023 @default.
• W2115086893 crossrefType "journal-article" @default.
• W2115086893 hasAuthorship W2115086893A5060855573 @default.
• W2115086893 hasAuthorship W2115086893A5066649593 @default.
• W2115086893 hasAuthorship W2115086893A5083326667 @default.
• W2115086893 hasAuthorship W2115086893A5086985620 @default.
• W2115086893 hasAuthorship W2115086893A5087834899 @default.
• W2115086893 hasAuthorship W2115086893A5089122298 @default.
• W2115086893 hasBestOaLocation W21150868931 @default.
• W2115086893 hasConcept C112705442 @default.
• W2115086893 hasConcept C145081991 @default.
• W2115086893 hasConcept C150903083 @default.
• W2115086893 hasConcept C185592680 @default.
• W2115086893 hasConcept C202751555 @default.
• W2115086893 hasConcept C207001950 @default.
• W2115086893 hasConcept C2777762789 @default.
• W2115086893 hasConcept C2779548794 @default.
• W2115086893 hasConcept C2780917455 @default.
• W2115086893 hasConcept C55493867 @default.
• W2115086893 hasConcept C71924100 @default.
• W2115086893 hasConcept C86803240 @default.
• W2115086893 hasConcept C89423630 @default.
• W2115086893 hasConcept C98274493 @default.
• W2115086893 hasConceptScore W2115086893C112705442 @default.
• W2115086893 hasConceptScore W2115086893C145081991 @default.
• W2115086893 hasConceptScore W2115086893C150903083 @default.
• W2115086893 hasConceptScore W2115086893C185592680 @default.
• W2115086893 hasConceptScore W2115086893C202751555 @default.
• W2115086893 hasConceptScore W2115086893C207001950 @default.
• W2115086893 hasConceptScore W2115086893C2777762789 @default.
• W2115086893 hasConceptScore W2115086893C2779548794 @default.
• W2115086893 hasConceptScore W2115086893C2780917455 @default.
• W2115086893 hasConceptScore W2115086893C55493867 @default.
• W2115086893 hasConceptScore W2115086893C71924100 @default.
• W2115086893 hasConceptScore W2115086893C86803240 @default.
• W2115086893 hasConceptScore W2115086893C89423630 @default.

• next